Recombinant protein expression is one of the key issues in protein engineering and biotechnology. Among the different models for assessing protein production and structure-function studies, green fluorescent protein (GFP) is one of the preferred models because of its importance as a reporter in cellular and molecular studies. In this research we analyze the effect of codon deletions near the amino terminus of different GFP proteins on fluorescence. Our study includes Gly4 deletions in the enhanced GFP (EGFP), the red-shifted GFP and the red-shifted EGFP. The Gly4 deletion mutants and their corresponding wild-type counterparts were transcribed under the control of the T7 or Trc promoters and their expression patterns were analyzed. Different fluorescent outcomes were observed depending on the type of fluorescent gene versions. In silico analysis of the RNA secondary structures near the ribosome binding site revealed a direct relationship between their minimum free energy and GFP production. Integrative analysis of these results, including SDS-PAGE analysis, led us to conclude that the fluorescence improvement of cells expressing different versions of GFPs with Gly4 deleted is due to an enhancement of the accessibility of the ribosome binding site by reducing the stability of the RNA secondary structures at their mRNA leader regions.

Keywords:
Heterologous protein expression, Fluorescent proteins, Codon deletions, Amino acid deletions, mRNA translation rate, mRNA secondary structure
1.
Amann E, Ochs B, Abel KJ: Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene 1988;69:301-315.
2.
Andronescu M, Condon A, Hoos HH, Mathews DH, Murphy KP: Computational approaches for RNA energy parameter estimation. RNA 2010;16:2304-2318.
3.
Arpino JAJ, Reddington SC, Halliwell LM, Rizkallah PJ, Jones DD: Random single amino acid deletion sampling unveils structural tolerance and the benefits of helical registry shift on GFP folding and structure. Structure 2014;22:889-898.
4.
Care S, Bignon C, Pelissier MC, Blanc E, Canard B, Coutard B: The translation of recombinant proteins in E. coli can be improved by in silico generating and screening random libraries of a -70/+96 mRNA region with respect to the translation initiation codon. Nucleic Acids Res 2008;36:e6.
5.
Cormack BP, Valdivia RH, Falkow S: FACS-optimized mutants of the green fluorescent protein (GFP). Gene 1996;173:33-38.
6.
Crameri A, Whitehorn EA, Tate E, Stemmer WP: Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol 1996;14:315-319.
7.
de Smit MH, van Duin J: Control of prokaryotic translational initiation by mRNA secondary structure. Prog Nucleic Acid Res Mol Biol 1990a;38:1-35.
8.
de Smit MH, van Duin J: Secondary structure of the ribosome binding site determines translational efficiency: a quantitative analysis. Proc Natl Acad Sci USA 1990b;87:7668-7672.
9.
Delagrave S, Hawtin RE, Silva CM, Yang MM, Youvan DC: Red-shifted excitation mutants of the green fluorescent protein. Biotechnology (NY) 1995;13:151-154.
10.
Dubendorff JW, Studier FW: Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor. J Mol Biol 1991;219:45-59.
11.
Flores-Ramírez G, Rivera M, Morales-Pablos A, Osuna J, Soberón X, Gaytán P: The effect of amino acid deletions and substitutions in the longest loop of GFP. BMC Chem Biol 2007;7:1.
12.
Gruber AR, Lorenz R, Bernhart SH, Neuböck R, Hofacker IL: The Vienna RNA websuite. Nucleic Acids Res 2008;36:W70-W74.
13.
Gu W, Zhou T, Wilke CO: A universal trend of reduced mRNA stability near the translation-initiation site in prokaryotes and eukaryotes. PLoS Comput Biol 2010;6:e1000664.
14.
Hall MN, Gabay J, Débarbouillé M, Schwartz M: A role for mRNA secondary structure in the control of translation initiation. Nature 1982;295:616-618.
15.
Heim R, Cubitt a B, Tsien RY: Improved green fluorescence. Nature 1995;373:663-664.
16.
Heim R, Prasher DC, Tsien RY: Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proc Natl Acad Sci USA 1994;91:12501-12504.
17.
Jones DD: Triplet nucleotide removal at random positions in a target gene: the tolerance of TEM-1 β-lactamase to an amino acid deletion. Nucleic Acids Res 2005;33:1-8.
18.
Knight JA, Hardy LW, Rennell D, Herrick D, Poteete AR: Mutations in an upstream regulatory sequence that increase expression of the bacteriophage T4 lysozyme gene. J Bacteriol 1987;169:4630-4636.
19.
Komarova AV, Tchufistova LS, Dreyfus M, Boni IV: AU-rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli. J Bacteriol 2005;187:1344-1349.
20.
Kudla G, Murray AW, Tollervey D, Plotkin JB: Coding-sequence determinants of gene expression in Escherichia coli. Science 2009;324:255-258.
21.
Li X, Zhang G, Ngo N, Zhao X, Kain SR, Huang CC: Deletions of the Aequorea victoria green fluorescent protein define the minimal domain required for fluorescence. J Biol Chem 1997;272:28545-28549.
22.
Liu S, Wei X, Dong X, Xu L, Liu J, Jiang B: Structural plasticity of green fluorescent protein to amino acid deletions and fluorescence rescue by folding-enhancing mutations. BMC Biochem 2015;16:17.
23.
Lorenz R, Bernhart SH, Höner zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL: ViennaRNA Package 2.0. Algorithms Mol Biol 2011;6:26.
24.
Mahalik S, Sharma AK, Mukherjee KJ: Genome engineering for improved recombinant protein expression in Escherichia coli. Microb Cell Fact 2014;13:177.
25.
Mathews DH, Disney MD, Childs JL, Schroeder SJ, Zuker M, Turner DH: Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. Proc Natl Acad Sci USA 2004;101:7287-7292.
26.
Merril CR, Gottesman ME, Adhya SL: Escherichia coli gal operon proteins made after prophage lambda induction. J Bacteriol 1981;147:875-887.
27.
Murakami H, Hohsaka T, Sisido M: Random insertion and deletion of arbitrary number of bases for codon-based random mutation of DNAs. Nat Biotechnol 2002;20:76-81.
28.
Osterman IA, Evfratov SA, Sergiev PV, Dontsova OA: Comparison of mRNA features affecting translation initiation and reinitiation. Nucleic Acids Res 2013;41:474-486.
29.
Osuna J, Yáñez J, Soberón X, Gaytán P: Protein evolution by codon-based random deletions. Nucleic Acids Res 2004;32:e136.
30.
Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ: Primary structure of the Aequorea victoria green-fluorescent protein. Gene 1992;111:229-233.
31.
Raghunathan G, Soundrarajan N, Sokalingam S, Yun H, Lee SG: Deletional protein engineering based on stable fold. PLoS One 2012;7:e51510.
32.
Seo SW, Yang JS, Kim I, Yang J, Min BE, Kim S, Jung GY: Predictive design of mRNA translation initiation region to control prokaryotic translation efficiency. Metab Eng 2013;15:67-74.
33.
Shaner NC, Patterson GH, Davidson MW: Advances in fluorescent protein technology. J Cell Sci 2007;120:4247-4260.
34.
Studer SM, Joseph S: Unfolding of mRNA secondary structure by the bacterial translation initiation complex. Mol Cell 2006;22:105-115.
35.
Torres Tejerizo G, Banuelos LA, Cervantes L, Gaytan P, Pistorio M, Romero D, Brom S: Development of molecular tools to monitor conjugative transfer in rhizobia. J Microbiol Methods 2015;117:155-163.
36.
Zimmer M: Green fluorescent protein (GFP): applications, structure, and related photophysical behavior. Chem Rev 2002;102:759-781.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.